Two service providers with similar offerings for biopharmaceutical, industrial, cosmetic and agricultural clients – Ginkgo Bioworks and Zymergen, Inc. – will combine under one name as Ginkgo takes advantage of difficult financial market conditions to acquire Zymergen in an all-stock transaction.
Both companies use synthetic biology and other technologies to enable more efficient drug development and manufacturing, and provide similar services...








